Madrigal registers Phase 4 safety study of Rezdiffra with diabetes drugs in MASH patientsSep 29Trial updateMadrigal Pharmaceuticals, Inc.resmetirom
Madrigal registers new Phase 1b trial testing resmetirom in MASH patients with HFpEFSep 21Trial updateMadrigal Pharmaceuticals, Inc.resmetirom
Madrigal registers pediatric Phase 2a trial of resmetirom for MASHAug 13Trial updateMadrigal Pharmaceuticals, Inc.resmetirom
Madrigal advances MGL-2086 into Phase 1, adds resmetirom patents, posts Q2 2026 resultsJul 30Quarterly updateMadrigal Pharmaceuticals, Inc.resmetirom
Sign inSign in